Review
Medicine, General & Internal
Alex H. Krist, Karina W. Davidson, Carol M. Mangione, Michael Cabana, Aaron B. Caughey, Esa M. Davis, Katrina E. Donahue, Chyke A. Doubeni, John W. Epling, Martha Kubik, Li Li, Gbenga Ogedegbe, Lori Pbert, Michael Silverstein, James Stevermer, Chien-Wen Tseng, John B. Wong
Summary: Age-related sensorineural hearing loss is a common health issue among adults, but the balance of benefits and harms of screening for hearing loss in asymptomatic adults aged 50 and older is uncertain, requiring further research.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Review
Medicine, General & Internal
Carol M. Mangione, Michael J. Barry, Wanda K. Nicholson, Michael Cabana, David Chelmow, Tumaini Rucker Coker, Esa M. Davis, Katrina E. Donahue, Carlos Roberto Jaen, Martha Kubik, Li Li, Gbenga Ogedegbe, Lori Pbert, John M. Ruiz, James Stevermer, John B. Wong
Summary: Genital herpes is a common sexually transmitted infection caused by herpes simplex viruses. It is a lifelong infection without a cure. Antiviral medications can help manage symptoms. Screening for HSV-2 infection in asymptomatic individuals is not recommended.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2023)
Article
Medicine, General & Internal
Laura Burgess, Christopher M. Aldrighetti, Anushka Ghosh, Andrzej Niemierko, Fumiko Chino, Melissa J. Huynh, Jason A. Efstathiou, Sophia C. Kamran
Summary: This study analyzed data from 1999 to 2019 and found that prostate cancer-specific mortality rates decreased or increased after the change in the 2012 USPSTF screening guideline, suggesting a possible association with decreased PSA screening.
Article
Gastroenterology & Hepatology
Uri Ladabaum, Ajitha Mannalithara, Manisha Desai, Maanek Sehgal, Gurkirpal Singh
Summary: This population-based study analyzed serious events associated with colonoscopy, finding that most serious non-gastrointestinal events were not directly related to the procedure, but were more common in older individuals. The study results can inform benefit-to-risk assessments for preventive colonoscopies.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2021)
Article
Oncology
Wenjie Ma, Kai Wang, Long H. Nguyen, Amit Joshi, Yin Cao, Reiko Nishihara, Kana Wu, Shuji Ogino, Edward L. Giovannucci, Mingyang Song, Andrew T. Chan
Summary: Evidence suggests that screening for colorectal cancer starting at 50 years old can detect early-stage cancer and prevent CRC-related mortality. A prospective cohort study in the US found that screening endoscopy after 75 years old was associated with a lower risk of CRC incidence and CRC-related mortality, supporting the continuation of screening after 75 years old among individuals without significant comorbidities.
Article
Public, Environmental & Occupational Health
Amy Lansky, Holly R. Wethington, Kelly Mattick, Marshall H. Chin, Anita Alston, Julie Racine-Parshall, Sophia L. Minor, Jamaicia Cobb, David P. Hopkins
Summary: This article describes the process and results of selecting priority topics to guide the work of the Community Preventive Services Task Force from 2020 to 2025. The task force started with Healthy People 2020 topics, solicited input from partner organizations and the public, and considered 8 criteria for each topic. After voting and applying decision rules, a total of 9 topics were selected as priorities.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE
(2022)
Article
Gastroenterology & Hepatology
Dylan E. O'Sullivan, Yibing Ruan, Winson Y. Cheung, Nauzer Forbes, Steven J. Heitman, Robert J. Hilsden, Darren R. Brenner
Summary: The incidence of early-onset colorectal cancer (eoCRC) has been increasing in North America, and there is still debate over the intervention from screening in this population. The incidence and histology of eoCRC differ between men and women, and adults aged 30 to 49 years have a higher risk of late-stage CRC. The findings support future modifications to screening guidelines for eoCRC in Canada and further research on the impact, cost-effectiveness, and risk prediction of targeted screening in this group.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2022)
Article
Oncology
Jan M. Eberth, Michael R. Gieske, Gerard A. Silvestri
Summary: Although the revised recommendations for lung cancer screening in the US offer potential benefits, members of the National Lung Cancer Roundtable warn of upcoming challenges. They stress the importance of a patient-centered approach that includes shared decision-making, improved access to care and navigation, and streamlined systems of care.
Article
Oncology
Marco Colamonici, Nader Khouzam, Catherine Dell, Kristin Auge-Bronersky, Esther Pacheco, Israel Rubinstein, Bradley Recht
Summary: This study successfully increased lung cancer screening referrals by primary care providers through patient education, shared decision-making, and tracking of initial LDCT completion. It was found that a proportion of patients did not show up for the screening, which may be influenced by racial and socioeconomic factors. Additionally, the initial lung cancer risk assessment reports had a slightly higher prevalence of higher-grade scores than expected. Therefore, a large-scale, multisite quality improvement project is needed to address transportation barriers in high-risk patient populations.
Article
Critical Care Medicine
Mary M. Pasquinelli, Martin C. Tammemagi, Kevin L. Kovitz, Marianne L. Durham, Zane Deliu, Arielle Guzman, Kayleigh Rygalski, Li Liu, Matthew Koshy, Patricia Finn, Lawrence E. Feldman
Summary: This study analyzed 883 lung cancer cases and compared the eligibility criteria of the USPSTF lung screening guidelines based on age and smoking history with the PLCOm2012 risk prediction model in terms of screening sensitivity and sex disparities. The results showed that the USPSTF 2021 criteria had higher sensitivity, but sex disparities in eligibility still existed. Adding the PLCOm2012 risk prediction model improved sensitivity and attenuated sex disparities.
Article
Medicine, General & Internal
John T. Schousboe, Brian L. Sprague, Linn Abraham, Ellen S. O'Meara, Tracy Onega, Shailesh Advani, Louise M. Henderson, Karen J. Wernli, Dongyu Zhang, Diana L. Miglioretti, Dejana Braithwaite, Karla Kerlikowske
Summary: The study found that extending screening mammography to age 80 may have benefits for some women, but the absolute reduction in death rates is small for women with comorbidities. Therefore, women over 75 should weigh the risks and benefits when considering screening mammography.
ANNALS OF INTERNAL MEDICINE
(2022)
Article
Medicine, General & Internal
John T. Schousboe, Brian L. Sprague, Linn Abraham, Ellen S. O'Meara, Tracy Onega, Shailesh Advani, Louise M. Henderson, Karen J. Wernli, Dongyu Zhang, Diana L. Miglioretti, Dejana Braithwaite, Karla Kerlikowske
Summary: Extending mammography screening to age 80 appears to be cost-effective in certain scenarios, but the absolute number of deaths averted is small, especially for women with comorbidities. Women considering screening beyond age 75 should carefully weigh the potential harms of overdiagnosis against the potential benefits of averting breast cancer death.
ANNALS OF INTERNAL MEDICINE
(2022)
Article
Medicine, General & Internal
Deborah A. Fisher, Nicole Princic, Lesley-Ann Miller-Wilson, Kathleen Wilson, A. Mark Fendrick, Paul Limburg
Summary: This study compared the use of CRC screening tests before and after the availability of the multitarget stool DNA (mt-sDNA) test, finding an increase in the proportion of individuals up to date with CRC screening between 2011 and 2019, but remained suboptimal. There were no substantial changes in the use of colonoscopy or FIT, with an increase in adoption of mt-sDNA and a decrease in the use of FOBT observed during the study period.
Article
Oncology
Martin Carl Tammemagi, Kristin Cina, Andrea K. Borondy Kitts, David Koop, Mark A. Petereit, Michele Sargent, Daniel G. Petereit
Summary: This study compared screening eligibility for lung cancer in South Dakota using different criteria and models. It found no disparities in eligibility for individuals self-reporting as Indigenous. The PLCOm2012 risk-prediction model showed higher sensitivity in identifying lung cancer cases for screening compared to the US Preventive Services Task Force (USPSTF) criteria. Screening individuals younger than 50 years did not seem necessary in this population.
Article
Public, Environmental & Occupational Health
Matthew J. O'Brien, Yan Zhang, Stacy C. Bailey, Sadiya S. Khan, Ronald T. Ackermann, Mohammed K. Ali, Stephen R. Benoit, Giuseppina Imperatore, Christopher S. Holliday, Kai McKeever Bullard
Summary: In 2021, the USPSTF recommended prediabetes and diabetes screening for asymptomatic adults aged 35-70 years with overweight/obesity. The study found that the 2021 criteria had higher sensitivity and lower specificity compared to the 2015 criteria, and screening all adults aged 35-70 years regardless of BMI had the most equitable performance across racial and ethnic groups.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE
(2023)